Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 210 of 5804
-
Brain zaps and yoga poses: new hope for Veterans' back pain?
Symptom relief Not yet recruitingThe objectives of this VA Merit application are to demonstrate efficacy of combined intermittent theta burst (iTBS) and yoga (iTBS+yoga) intervention on improving pain, function, analgesic use, self-efficacy, quality of life and well-being among Veterans with chronic low back pai…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New study tests orbital atherectomy to save limbs in patients with severe leg artery disease
Disease control Not yet recruitingORACLE is a Europe-wide study that will follow 250 people with critical limb-threatening ischemia (CLTI). It aims to see how well orbital atherectomy (OA) works in real-life practice. OA is a procedure that uses a tiny spinning tool to gently remove hard calcium from inside an ar…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Major trial to determine best drug for rare autoimmune disease
Disease control Not yet recruitingNeuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune condition that mainly affects the eyes and spinal cord, causing serious symptoms such as vision loss, paralysis, and severe pain. This trial compares the effectiveness and safety of five medications commonly used…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Smarter scans for breast cancer survivors: could personalized imaging catch recurrences earlier?
Diagnosis Not yet recruitingBreast cancer follow-up after curative treatment is currently based on largely uniform imaging surveillance strategies, despite substantial variation in recurrence risk across patient subgroups. Early detection of recurrences improves prognosis, particularly when detected by imag…
Phase: NA • Sponsor: Umeå University • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New drug combo aims to make inoperable bile duct cancer removable
Disease control Recruiting nowThis study is being conducted to find out if treatment with gemcitabine, cisplatin, nab-paclitaxel, and cemiplimab can shrink previously inoperable tumors enough for surgery.
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug could beat steroids for saving sight in thyroid eye disease
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of sequential Teprotumumab N01 compared with intravenous methylprednisolone (IVMP) after urgent orbital decompression in patients with dysthyroid optic neuropathy (DON).
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New heart valve device aims to ease severe leak
Disease control Not yet recruitingPivotal trial to evaluate the safety and effectiveness of the P\&F TricValve® Transcatheter Bicaval Valve System.
Phase: NA • Sponsor: P+F Products + Features USA Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a schizophrenia drug curb Cocaine's grip?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Cobenfy influences the effects of cocaine in people with cocaine use disorder. This trial will also provide information about the safety and tolerability of combining Cobenfy and cocaine. Researchers will compare Cobenfy to a placeb…
Phase: PHASE1, PHASE2 • Sponsor: Joshua A. Lile, Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to tame cholesterol side effect of lung cancer drug
Disease control Not yet recruitingFor Patients and Families Brief Title: Management of 1L Lorlatinib with Hyperlipidemia in ALK+ Advanced NSCLC What is this study about? This study is for people with ALK-positive non-small cell lung cancer (NSCLC) who are taking lorlatinib (Lorbrena®) as their first treatment …
Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Virtual reality could help stroke survivors walk again in the real world
Disease control Recruiting nowThe purpose of this study is to evaluate a new virtual reality (VR)-based rehabilitation program designed to help stroke survivors improve their walking abilities in real-world settings. By comparing immersive VR-assisted overground gait therapy to contemporary non-immersive, tre…
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug GEN1119 aims to fight solid tumors that resist standard care
Disease control Not yet recruitingThe purpose of this trial is to learn about the safety and efficacy of GEN1119 when it is used for the treatment of participants with certain types of cancer. The trial has multiple parts. The first part of the trial will test different doses of GEN1119 to find out if it is safe…
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Handheld ultrasound could spot hidden graft failures during bypass surgery
Disease control Not yet recruitingThis single-center, randomized, controlled trial aims to evaluate whether intraoperative portable ultrasound monitoring can improve early postoperative outcomes in patients undergoing coronary artery bypass grafting (CABG). A total of 380 patients scheduled for elective CABG at …
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Virus therapy aims to boost chemo in tough pancreatic cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the new administration regimen of VCN-01, given together with the standard chemotherapy drugs gemcitabine and nab-paclitaxel (GnP), is safe and well tolerated. The behaviour of VCN-01 in the organism will be assessed, together with t…
Phase: PHASE1, PHASE2 • Sponsor: Theriva Biologics SL • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a targeted drug re-sensitize resistant breast cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if alisertib in addition to usual care works to treat HR+/HER2+ breast cancer. The main questions it aims to answer are: * Does alisertib stop the communication between HR and HER2? * Are there genetic markers that predict how well som…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Blood filtering may save children with sepsis
Disease control Not yet recruitingThe aim of the study will be to to evaluate whether therapeutic plasma exchange (TPE) reduces mortality in critically ill children with severe sepsis or septic shock compared to the standard care of sepsis alone. The study population will be divided into two groups, the first gr…
Phase: NA • Sponsor: Menoufia University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can a nanoparticle deliver chemo more safely to Hard-to-Treat cancers?
Disease control Not yet recruitingThis is an open-label, multi-center, phase 1/2 dose-escalation and dose expansion study evaluating the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of ML-016 in participants with advanced solid tumors with lung and/or liver involvement (primary or metastat…
Phase: PHASE1, PHASE2 • Sponsor: BrYet US, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a targeted pill boost Chemo's power against a rare blood cancer?
Disease control Not yet recruitingThis is a single-arm, multicenter, Phase Ib/IIa study designed to explore the efficacy and safety of SHR2554 in combination with liposomal mitoxantrone for the treatment of patients with treatment-naive peripheral T-cell lymphoma (PTCL). The study is divided into a Phase Ib safet…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Ancient herbs vs. superbugs: can TCM prevent repeat pneumonia?
Disease control Not yet recruitingThis is a multicenter prospective observational cohort study of hospitalized adults with drug-resistant bacterial pneumonia. The study will compare patients who receive systemic traditional Chinese medicine treatment during routine clinical care with those who do not receive syst…
Sponsor: Henan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a biologic drug calm the gut in ulcerative colitis? a Real-World trial seeks answers
Disease control Not yet recruitingIn a real-world setting, this study systematically evaluates the clinical efficacy and safety of guselkumab (GUS) in the treatment of ulcerative colitis (UC), encompassing multi-dimensional outcomes including clinical remission, biochemical remission, endoscopic remission, histol…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a Two-Drug combo outsmart Hard-to-Treat lymphoma?
Disease control Not yet recruitingThis is a single-arm, multi-cohort, multicenter, phase Ib/IIa clinical study designed to evaluate the safety and efficacy of Zeprumetostat (an EZH2 inhibitor) in combination with different therapeutic agents/regimens - specifically, the JAK1 inhibitor golidocitinib and the GemOx …
Phase: PHASE1, PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC